Clinical trial
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation
NCT05848284 is registered in ClinicalTrials.gov with VDyne, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation
- Lead sponsor
- VDyne, Inc.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 1, 2024
- Completion date
- November 30, 2031
- Enrollment
- 30 (estimated)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
tricuspid regurgitation, tricuspid valve disease, tricuspid valvular disorders